Evidence for lipid-dependent structural changes in specific domains of apolipoprotein B100

Biochemistry. 1998 Mar 17;37(11):3735-42. doi: 10.1021/bi9718853.

Abstract

The structural organization and stability of apoB100 in complexes containing triglyceride (TG) and phospholipid have been examined. LDL was delipidated to form aqueous soluble apoB100-TG complexes that retain approximately 70% of LDL TG, but contain no other lipids. The apoB100-TG complexes exhibited reduced amphipathic alpha-helical content (17%) and net negative charge (-2.9 mV) as compared to native LDL-apoB100 (49% and -6 mV, respectively). Of 28 anti-apoB monoclonal antibodies tested, 15 showed partial or full reactivity with apoB100-TG. The immunoreactive epitopes of apoB100-TG were restricted to those situated in either the amino terminal globular domain (4 of 6) or in regions of apoB100 that are predicted to be composed of amphipathic beta-strands (11 of 13). Incubation of the apoB100-TG complex with palmitoyloleoylphosphatidylcholine (POPC) spontaneously (< 10 min) formed homogeneous lipoproteins (20 nm) that contained approximately 300 molecules of POPC per particle (apoB100-PC). Phospholipidation of apoB100-TG complexes partially recovered the alpha-helical content (34%) and net negative charge (-4.9 mV) of the native LDL and restored resistance of apoB100 to denaturation by guanidine HCl (5.8 M). Addition of phospholipids to apoB100-TG also increased the immunoreactivity of specific epitopes that are located primarily in regions of apoB100 that are thought to be constituted of amphipathic beta-strands. The effects of TG and phospholipid on apoB100 conformation appear to be highly domain-specific. On the basis of these results, we propose that the beta-strands of apoB100 may represent a nonflexible lipid-associating backbone, while the amphipathic alpha-helical domains may represent flexible lipid-binding regions that allow the particle to accommodate varying amounts of lipid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / metabolism
  • Apolipoprotein B-100
  • Apolipoproteins B / chemistry*
  • Apolipoproteins B / immunology
  • Apolipoproteins B / metabolism
  • Cells, Cultured
  • Deoxycholic Acid
  • Dimyristoylphosphatidylcholine / metabolism
  • Fibroblasts
  • Humans
  • Lipid Metabolism
  • Lipids / physiology*
  • Lipoproteins, LDL / metabolism
  • Phosphatidylcholines / metabolism
  • Protein Binding
  • Protein Structure, Secondary
  • Protein Structure, Tertiary*
  • Receptors, LDL / metabolism
  • Triglycerides / metabolism

Substances

  • Antibodies, Monoclonal
  • Apolipoprotein B-100
  • Apolipoproteins B
  • Lipids
  • Lipoproteins, LDL
  • Phosphatidylcholines
  • Receptors, LDL
  • Triglycerides
  • Deoxycholic Acid
  • 1-palmitoyl-2-oleoylphosphatidylcholine
  • Dimyristoylphosphatidylcholine